CD34 and myelodysplastic syndrome: The miR-155-5p molecule plays a role in the programmed cell death of CD34 + cells in Myelodysplastic Syndromes (MDS) through the RAC1/CREB/miR-15b pathway, thereby suppressing the production of blood cells in the bone marrow.